Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of Development of Transcutaneous Sensitization in Children With Atopic Dermatitis During Their First Year of Life: an Observational Study

NCT04900948 is registered in ClinicalTrials.gov with National Medical Research Center for Children's Health, Russian Federation as lead sponsor.

NCT NCT04900948
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04900948 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of Development of Transcutaneous Sensitization in Children With Atopic Dermatitis During Their First Year of Life: an Observational Study
Lead sponsor
National Medical Research Center for Children's Health, Russian Federation
Phase
Phase 4
Overall status
Completed
Start date
December 10, 2017
Completion date
April 25, 2020
Enrollment
108 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atopic dermatitis